摘要
目的探究肺癌检验和诊断中肿瘤标志物检验的应用效果。方法选取2017年3月至2018年9月本院收治的肺癌患者30例与良性肺部病变患者30例,分别纳入观察组与研究组,并将同期来本院进行健康体检的无肺部疾病者30例作为对照组。3组均取3 ml清晨空腹静脉血,离心处理后获取血清样本,行肿瘤标志物检验并对比检验结果。结果在NSE、CEA、CA125、CYFRA21-1四项肿瘤标志物指标水平方面,3组结果比较差异具有统计学意义(P<0.05)。结论肿瘤标志物检验在肺癌检验与诊断中具有较高的临床应用价值,临床肺癌诊疗时可根据肿瘤标志物检验结果作为判断依据。
Objective To observe the application effect of tumor markers in lung cancer detection and diagnosis. Methods 30 patients with lung cancer and 30 patients with benign pulmonary diseases admitted to our hospital from March 2017 to September 2018 were enrolled in the observation group and the research group respectively, and 30 patients without lung diseases who underwent health examination in our hospital during the same period were taken as the control group. 3 ml morning fasting venous blood was taken from all three groups, centrifugal obtaining serum samples, after processing line of tumor markers test and contrast test results. Results In terms of NSE, CEA, CA125 and CYFRA21-1, the results of the three groups were significantly different(P<0.05). Conclusion The detection of tumor markers has high clinical application value in the detection and diagnosis of lung cancer.
作者
廖莎莎
Liao Shasha(Canzhou People's Hospital,Ganzhou,Jiangxi,341000,China)
出处
《当代医学》
2019年第34期119-121,共3页
Contemporary Medicine
关键词
肺癌
诊断
肿瘤标志物
检验
Lung cancer
Diagnosis
Tumor markers
Inspection
